SK282124B6 - Heteroaroylové deriváty monocyklických beta-laktámových antibiotík, spôsob ich prípravy a medziprodukty - Google Patents

Heteroaroylové deriváty monocyklických beta-laktámových antibiotík, spôsob ich prípravy a medziprodukty Download PDF

Info

Publication number
SK282124B6
SK282124B6 SK3345-91A SK334591A SK282124B6 SK 282124 B6 SK282124 B6 SK 282124B6 SK 334591 A SK334591 A SK 334591A SK 282124 B6 SK282124 B6 SK 282124B6
Authority
SK
Slovakia
Prior art keywords
formula
group
compound
amino
general formula
Prior art date
Application number
SK3345-91A
Other languages
English (en)
Slovak (sk)
Inventor
William H. Koster
Joseph E. Sundeen
Henner Straub
Peter Hans Ermann
Uwe D. Treuner
Original Assignee
E. R. Squibb & Sons, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by E. R. Squibb & Sons, Inc. filed Critical E. R. Squibb & Sons, Inc.
Publication of SK282124B6 publication Critical patent/SK282124B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40—Benzopyrazines
    • C07D241/42—Benzopyrazines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/50—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms
    • C07D241/52—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/78—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C217/80—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings
    • C07C217/82—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring
    • C07C217/84—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring the oxygen atom of at least one of the etherified hydroxy groups being further bound to an acyclic carbon atom
    • C07C217/86—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring the oxygen atom of at least one of the etherified hydroxy groups being further bound to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/62—Compounds containing any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylcarbamates
    • C07C271/66—Y being a hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40—Benzopyrazines
    • C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
    • C07F9/650994—Six-membered rings having the nitrogen atoms in the positions 1 and 4 condensed with carbocyclic rings or carbocyclic ring systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Luminescent Compositions (AREA)
SK3345-91A 1990-11-05 1991-11-05 Heteroaroylové deriváty monocyklických beta-laktámových antibiotík, spôsob ich prípravy a medziprodukty SK282124B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60894590A 1990-11-05 1990-11-05

Publications (1)

Publication Number Publication Date
SK282124B6 true SK282124B6 (sk) 2001-11-06

Family

ID=24438745

Family Applications (1)

Application Number Title Priority Date Filing Date
SK3345-91A SK282124B6 (sk) 1990-11-05 1991-11-05 Heteroaroylové deriváty monocyklických beta-laktámových antibiotík, spôsob ich prípravy a medziprodukty

Country Status (27)

Country Link
US (3) US5290929A (cs)
EP (1) EP0484881B1 (cs)
JP (2) JP3157565B2 (cs)
KR (4) KR100210631B1 (cs)
CN (3) CN1159303C (cs)
AT (1) ATE178604T1 (cs)
AU (2) AU648835B2 (cs)
CA (1) CA2053359C (cs)
CZ (1) CZ289671B6 (cs)
DE (1) DE69131090T2 (cs)
DK (1) DK0484881T3 (cs)
ES (1) ES2129397T3 (cs)
FI (1) FI915194L (cs)
GR (1) GR3030572T3 (cs)
HU (1) HU211402B (cs)
IE (1) IE913565A1 (cs)
IL (3) IL118368A (cs)
MX (1) MX9101767A (cs)
MY (2) MY107454A (cs)
NO (1) NO914320L (cs)
NZ (5) NZ272438A (cs)
PL (1) PL167312B1 (cs)
PT (1) PT99427A (cs)
SK (1) SK282124B6 (cs)
UY (1) UY23318A1 (cs)
YU (1) YU175791A (cs)
ZA (1) ZA918014B (cs)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5232918A (en) * 1987-07-23 1993-08-03 Imperial Chemical Industries Plc Cephalosporin derivatives
ZA918014B (en) * 1990-11-05 1992-07-29 Squibb & Sons Inc Heteroaroyl derivatives of monocyclic beta-lactam antibiotics
US5250691A (en) * 1991-09-09 1993-10-05 E. R. Squibb & Sons, Inc. Heteroaryl derivatives of monocyclic beta-lactam antibiotics
US5888998A (en) * 1997-04-24 1999-03-30 Synphar Laboratories, Inc. 2-oxo-1-azetidine sulfonic acid derivatives as potent β-lactamase inhibitors
US5994340A (en) * 1997-08-29 1999-11-30 Synphar Laboratories, Inc. Azetidinone derivatives as β-lactamase inhibitors
KR100702878B1 (ko) * 1999-10-29 2007-04-04 넥타르 테라퓨틱스 개선된 분산성을 갖는 건조 분말 조성물
US20030133925A1 (en) * 2001-09-28 2003-07-17 Shawar Ribhi M. Monobactam compositions and methods of use thereof
CN102988362B (zh) * 2005-12-07 2014-11-05 巴斯利尔药物股份公司 单环-内酰胺类抗生素与β-内酰胺酶抑制剂的有效的联合应用
UY34585A (es) 2012-01-24 2013-09-02 Aicuris Gmbh & Co Kg Compuestos b-lactámicos sustituidos con amidina, su preparación y uso
CN103896964B (zh) * 2014-03-31 2016-04-13 南京工业大学 一类头孢中间体的制备方法
KR101583937B1 (ko) * 2014-06-09 2016-01-08 현대자동차주식회사 자동차용 연료센더 장치
CN105017167B (zh) * 2015-07-20 2017-10-20 新乡医学院 一种喹喔啉类化合物的制备方法
MX2019007613A (es) 2016-12-21 2019-09-04 Aicuris Gmbh & Co Kg Terapia de combinacion con compuestos ?-lactamicos sustituidos con amidina e inhibidores de ?-lactamasa para infecciones con cepas bacterianas resistentes a antibioticos.
EP3747883A4 (en) 2018-01-29 2020-12-16 Medshine Discovery Inc. B-LACTAM MONOCYCLIC COMPOUND FOR TREATMENT OF BACTERIAL INFECTION
WO2020125670A1 (zh) 2018-12-18 2020-06-25 南京明德新药研发有限公司 单环β-内酰胺化合物在制药中的应用
US20230022708A1 (en) 2019-12-19 2023-01-26 Medshine Discovery Inc. Application of compound in drug preparation
KR20230163532A (ko) 2021-03-31 2023-11-30 페도라 파마슈티칼스 인코포레이티드 락티비신 화합물, 이의 제조 및 항균제로서의 용도
PE20241516A1 (es) * 2021-11-18 2024-07-19 Merck Sharp And Dohme Llc Compuestos monobactamicos de cromano amidina para tratar las infecciones bacterianas

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1408675A (en) * 1973-03-16 1975-10-01 Allen & Hanburys Ltd Amides derived from quinoxaline
US4217453A (en) * 1978-07-24 1980-08-12 Merck & Co., Inc. 6-Amido-3-substituted-amino-1-azabicyclo[3.2.0]hept-2-en-7-one-2-carboxylic acid
PH15791A (en) * 1978-10-20 1983-03-25 Lilly Co Eli Pharmaceutical composition containing 3,4-dihydro-3-oxoquinoxalines
US4224336A (en) * 1979-04-17 1980-09-23 Merck & Co., Inc. 3-(2-Aminoethylthio)-6-amido-7-oxo-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid
US4775670A (en) * 1980-09-29 1988-10-04 E. R. Squibb & Sons, Inc. 2-oxo-1-azetidinesulfonic acid salts
US4587047A (en) * 1981-04-09 1986-05-06 E. R. Squibb & Sons, Inc. 2-oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines
US4670553A (en) * 1982-01-04 1987-06-02 E. R. Squibb & Sons, Inc. 2-oxo-1-(aminocarbonylaminosulfonyl-aminocarbonyl)azetidines
US4566876A (en) * 1983-03-10 1986-01-28 Clairol Incorporated Meta-phenylenediamine coupler compounds and oxidative hair dye compositions and methods using same
US4610824A (en) * 1984-10-09 1986-09-09 E. R. Squibb & Sons, Inc. Hydrazide derivatives of monocyclic beta-lactam antibiotics
US4743685A (en) * 1985-09-26 1988-05-10 E. R. Squibb & Sons, Inc. 2-oxo-1-[[(substituted sulfonyl)amino]carbonyl]azetidines
FI872879A7 (fi) * 1986-07-21 1988-01-22 Sankei Yakuhin Kk --laktamfoerening, foerfarande foer dess framstaellning, denna innehaollande laekemedelskomposition foer behandling av sjukdom med bakterieinfektion samt mellanprodukter foer dess syntes.
US4772693A (en) * 1987-07-01 1988-09-20 E. R. Squibb & Sons, Inc. 2-oxo-1-((Substituted sulfonyl)amino)-carbonyl)azetidines
GB8816519D0 (en) * 1987-07-23 1988-08-17 Ici Plc Antibiotic compounds
US4904775A (en) * 1988-05-16 1990-02-27 E. R. Squibb & Sons, Inc. Heteroaroylhydrazide derivatives of monocyclic beta-lactam antibiotics
US5037983A (en) * 1988-05-16 1991-08-06 E. R. Squibb & Sons, Inc. 6,7-dihydroxyquinoxalines as intermediates to beta-lactam antibiotics
US4959470A (en) * 1988-08-17 1990-09-25 E. R. Squibb & Sons, Inc. 2-oxo-[[(substituted sulfonyl)-amino]carbonyl]-azetidines
CA2024282A1 (en) * 1989-09-21 1991-03-22 Peter H. Ermann Heterocyclic hydrazide derivatives of monocyclic beta-lactam antibiotics
US5030724A (en) * 1990-01-22 1991-07-09 E. R. Squibb & Sons, Inc. Monobactam hydrazides containing catechol sulfonic acid groups
ZA918014B (en) * 1990-11-05 1992-07-29 Squibb & Sons Inc Heteroaroyl derivatives of monocyclic beta-lactam antibiotics
US5250691A (en) * 1991-09-09 1993-10-05 E. R. Squibb & Sons, Inc. Heteroaryl derivatives of monocyclic beta-lactam antibiotics

Also Published As

Publication number Publication date
IL99829A0 (en) 1992-08-18
IL118368A0 (en) 1996-09-12
EP0484881A3 (en) 1992-10-14
JP3157565B2 (ja) 2001-04-16
FI915194A7 (fi) 1992-05-06
ES2129397T3 (es) 1999-06-16
CA2053359A1 (en) 1992-05-06
NZ272437A (en) 1997-01-29
CN1067053C (zh) 2001-06-13
PT99427A (pt) 1992-09-30
CN1251836A (zh) 2000-05-03
CZ289671B6 (cs) 2002-03-13
JPH04283579A (ja) 1992-10-08
AU648835B2 (en) 1994-05-05
NZ272438A (en) 1997-01-29
CN1159303C (zh) 2004-07-28
JP3299734B2 (ja) 2002-07-08
CN1113228A (zh) 1995-12-13
CN1061414A (zh) 1992-05-27
KR100221505B1 (ko) 2000-03-15
CA2053359C (en) 2004-01-13
YU175791A (sh) 1994-01-20
IL118368A (en) 1997-09-30
DE69131090D1 (de) 1999-05-12
KR100210631B1 (ko) 1999-07-15
MX9101767A (es) 1992-07-08
FI915194L (fi) 1992-05-06
MY113385A (en) 2002-02-28
IL118367A0 (en) 1996-09-12
ATE178604T1 (de) 1999-04-15
US5705645A (en) 1998-01-06
KR100248590B1 (en) 2000-03-15
HU913462D0 (en) 1992-01-28
EP0484881B1 (en) 1999-04-07
PL292287A1 (en) 1992-06-01
KR920009827A (ko) 1992-06-25
CS334591A3 (en) 1992-05-13
NZ260513A (en) 1997-01-29
PL167312B1 (pl) 1995-08-31
NZ280077A (en) 1997-01-29
AU659780B2 (en) 1995-05-25
KR100228469B1 (ko) 2000-03-15
IE913565A1 (en) 1992-05-22
HU211402B (en) 1995-11-28
GR3030572T3 (en) 1999-10-29
DK0484881T3 (da) 1999-10-18
ZA918014B (en) 1992-07-29
MY107454A (en) 1995-12-30
DE69131090T2 (de) 1999-09-23
NZ240382A (en) 1997-01-29
JP2000239246A (ja) 2000-09-05
NO914320L (no) 1992-05-06
IL99829A (en) 1997-01-10
US5420277A (en) 1995-05-30
EP0484881A2 (en) 1992-05-13
AU6889294A (en) 1994-10-06
FI915194A0 (fi) 1991-11-04
NO914320D0 (no) 1991-11-04
UY23318A1 (es) 1992-04-24
CN1031825C (zh) 1996-05-22
AU8694191A (en) 1992-05-07
US5290929A (en) 1994-03-01
HUT59921A (en) 1992-07-28

Similar Documents

Publication Publication Date Title
SK282124B6 (sk) Heteroaroylové deriváty monocyklických beta-laktámových antibiotík, spôsob ich prípravy a medziprodukty
EP0277836B1 (en) Thiazolidinone derivatives, their preparation and their use
DE3546658C2 (cs)
EP4495113A1 (en) Kif18a inhibitor
KR102842676B1 (ko) Khk 억제 효과를 갖는 화합물
EP4001276A1 (en) Aurora kinase inhibitor and use thereof
KR20210136995A (ko) 브루톤 티로신 키나아제 억제제
EP1439164B1 (en) Novel phenylethanolamine compounds having beta2-acceptor excitatory function and their preparation method
AU2021358074A1 (en) Acetamido-phenyltetrazole derivatives and methods of using the same
WO2018211323A1 (en) Hetercyclic compounds for the treatment of disease
CZ177892A3 (en) AMINOMETHYL SUBSTITUTED 2,3-DIHYDROPYRAN(2,3-b)PYRIDINES, PROCESS OF THEIR PREPARATION AND THEIR USE IN MEDICAMENTS
HUT74883A (en) New process and intermediates for preparing naphthyridonecarboxylic acid salts
JPS63166876A (ja) ピリドンカルボン酸誘導体
HK1214244A1 (zh) 咪唑并吡啶衍生物
PL143943B1 (en) Method of obtaining novel beta-lactam esters of 6-alpha- and 6-beta-/aminomethyl/penicillanic acid 1,1-dioxide
US5929240A (en) Process and intermediates for preparing naphthyridonecarboxylic acid salts
US10618892B2 (en) Processes for the preparation of a BACE inhibitor
AU2023299045A1 (en) Novel indenone derivatives and uses thereof
NZ739940A (en) Fused ring pyrimidine compound, intermediate, and preparation method, composition and use thereof
NZ739940B2 (en) Fused ring pyrimidine compound, intermediate, and preparation method, composition and use thereof
JPH07196659A (ja) ２−［（置換−１，３−チアゾリウム−３−イル）アルキルチオ］カルバペネム誘導体